Compound: AOD-9604 (hGH 177191 fragment, Tyr-modified)
Numerous studies have found a positive correlation between obesity and breast cancer incidence, recurrence, and mortality, particularly in postmenopausal patients with estrogen receptor-positive breast cancer, and pre-menopausal triple negative breast cancer (TNBC) (48)
[1] Contamination risks, potency variations, and sterility concerns represent significant potential hazards with compounded injectable medications
It provides more robust and clinically validated GH stimulation than sermorelin alone, with demonstrated body composition effects documented in randomized controlled trials
Immune cells can also produce NO in the oxidative burst during inflammation
Sorbitan Olivate also helps hydrate the skin